Implementing Diverse Tumor Models to Study & Develop Oncolytic Virus Therapies
Time: 2:15 pm
day: Conference Day One - Track 1 - Post Lunch
Details:
- Highlighting the importance of understanding the dynamic interplay between oncolytic viruses and the immune system within tumor models to optimize therapeutic outcomes
- Addressing challenges such as virus delivery, tumor heterogeneity, and more, and strategies to overcome these hurdles
- Presenting strategies to overcome the discrepancies between data from different tumor models
